Cerebral phaeohyphomycosis: The 'Dark Side' of fungal infections.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
03 2022
Historique:
received: 10 11 2021
revised: 14 01 2022
accepted: 08 02 2022
pubmed: 18 2 2022
medline: 15 4 2022
entrez: 17 2 2022
Statut: ppublish

Résumé

Cerebral phaeohyphomycosis is a rare and fatal fungal infection of the central nervous system (CNS) caused by dematiaceous fungi. The aim of this study was to analyse the clinico- radiological presentation, pathology and outcome of cerebral phaeohyphomycosis and discuss the relevant literature. Data of 7 patients diagnosed with cerebral phaeohyphomycosis and managed at our institute between 2014 and 2020 was collected and reviewed retrospectively. The diagnosis was established after surgery on KOH mount, Sabouraud dextrose agar, frozen section or histopathology. The clinical, radiological and pathological characteristics along with outcomes were analysed. Three patients with underlying comorbidities [chronic renal failure-2 and haematological malignancy -1] presented with brain abscess. The remaining 4 had no comorbidities. Two of them mimicked cystic glioma and one patient presented as intraventricular tumour. Another patient on anti- tubercular treatment for suspected pulmonary tuberculosis presented with encephalitis. Histopathology in all patients showed diffuse micro abscesses with coarse and reactive gliosis in the adjacent brain parenchyma and chronic lymphomononuclear inflammation without angioinvasion or vasculitis. Four showed granuloma formation. Antifungals were started after diagnosis. Six out of seven patients died and one was lost to follow up. Cerebral phaeohyphomycosis presents as abscesses in immunocompromised patients and mimics tumours in immunocompetent patients. KOH mount and frozen section examination is simple yet effective tool for establishing early diagnosis. Overall, the prognosis is dismal. Administering antifungals early in the course of management along with aggressive surgical excision may improve outcomes.

Identifiants

pubmed: 35176635
pii: S0303-8467(22)00054-3
doi: 10.1016/j.clineuro.2022.107173
pii:
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107173

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Archit Latawa (A)

Department of Neurosurgery, PGIMER, Chandigarh, India. Electronic address: dr.archit@gmail.com.

Ipsita Panda (I)

Department of Histopathology, PGIMER, Chandigarh, India. Electronic address: simplyipsi@gmail.com.

Harsimran Kaur (H)

Department of Microbiology, PGIMER, Chandigarh, India. Electronic address: drharsimranpgi@gmail.com.

Ashish Aggarwal (A)

Department of Neurosurgery, PGIMER, Chandigarh, India. Electronic address: aaggarwal_7@yahoo.com.

Bishen D Radotra (BD)

Department of Histopathology, PGIMER, Chandigarh, India. Electronic address: bishan_radotra@gmail.com.

Kirti Gupta (K)

Department of Histopathology, PGIMER, Chandigarh, India. Electronic address: kirtigupta10@yahoo.co.in.

Pravin Salunke (P)

Department of Neurosurgery, PGIMER, Chandigarh, India. Electronic address: drpravin_salunke@yahoo.co.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH